Envoy Medical (Envoy Medical) Debt-to-Revenue : 22.70 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Envoy Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.16 Mil. Envoy Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $5.20 Mil. Envoy Medical's annualized Revenue for the quarter that ended in Mar. 2024 was $0.24 Mil. Envoy Medical's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 22.69.

Envoy Medical Debt-to-Revenue Historical Data

The historical data trend for Envoy Medical's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Debt-to-Revenue Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Revenue

75.73

145.72

1.78

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial				-	224.66	1.84	1.48	22.70

Competitive Comparison of Envoy Medical's Debt-to-Revenue

For the Medical Devices subindustry, Envoy Medical's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Envoy Medical's Debt-to-Revenue falls into.

Envoy Medical Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Envoy Medical's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.158	+	0.404)	/	0.316
	=	1.78

Envoy Medical's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.157	+	5.199)	/	0.236
	=	22.69

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.

Envoy Medical Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Envoy Medical's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.